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The results of previous studies on the distribution by age of  antibodies  to 
influenza viruses  have shown a  remarkable  correlation between  the  type of 
antibody found now in  the sera  of persons at  three  stages  of  life,  and  the 
antigenic character of the strains prevalent during the childhood of each age 
group (1-4). 
For example, the principle antibody of children born after the appearance 
of influenza A-prime in 1946 is antibody that reacts with A-prime strains. The 
principle antibody of young  adults  who were children during  the period of 
prevalence of influenza A, which extended until 1943,  is antibody that reacts 
with strains of Type A  influenza virus. Likewise, in persons over 30 years of 
age, the principal antibody recognized is one that reacts with swine influenza 
virus. Many of the persons now over 30 years of age were children during a 
period when influenza viruses antigenically closely related to swine strains are 
presumed to have prevailed. This period included the pandemic of 1918  (5, 6, 
1--4). Analogous results have been found with respect to antigenic variants of 
Type B  influenza virus and  influenza B  (1,  2). 
To explain these  phenomena  the thesis was  presented  that at  the time of 
the  initial  infections with  influenza  viruses,  which  occur predominantly  in 
childhood,  the  antibody-forming  mechanisms  are  persistently  oriented  by 
the dominant antigens of the strains encountered. Upon subsequent exposure to 
influenza viruses of varied but related antigenic  composition reinforcement of 
the  level of  antibody  to  the  strains  of  primary  infection occurs  while  the 
serologic response to prevailing viruses may be dampened. This thesis has been 
epitomized in  a  colloquial expression as  "the  doctrine of original  antigenic 
sin." It was previously stated that the data which led to formulation of this 
"doctrine" were in part derived by measuring interepidemic levels of antibody 
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with prototypic strains of virus. Under these circumstances, the time, rate, and 
character of prior antigenic exposures of the population studied are not precisely 
known. In order  to  define more accurately the  dimensions of  the persistent 
serologic influences of the dominant antigens of the strains of childhood infec- 
tion, it was decided to control these variables by vaccination with monovalent 
vaccines containing representative strains of swine influenza, influenza A, and 
influenza A-prime. The vaccines were given to children born during the period 
of prevalence of influenza  A-prime, to adults who were children during the epoch 
of influenza A, and to adults over 30 years of age. Antibody response in each 
age group was measured with each strain of virus.  In addition, it was recog- 
nized that the data obtained might provide a  serologic index of  the  relative 
extent of  the antigenic experience of  these segments of  the population with 
influenza A,  A-prime, and swine-like strains. It is believed that  this  use of 
vaccines to assess the relative frequency of infection in a  population represents 
a  new development in serologic epidemiology. 
Materials and Methods 
Vazo/nes.--Monovalent influenza virus vaccines, each containing 750 CCA units of virus 
per  ml., were prepared  by a  commercial pharmaceutical  firm with  the following strains: 
Swine 1976 (1931), PR8 (1933), FM1 (1947), and Cuppett  (1950). The viruses were inacti- 
vated  with formalin (1:4000). Merthiolate  (1:10,000) was added as a preservative.  Inad- 
vertently,  the monovalent Cuppett  vaccine contained a  trace of  Conley virus (1952 A'), 
but in an amount judged to be too small to influence the results obtained. 
Subjects.--Antibody  response to  these  experimental vaccines was  studied  in  children 
aged 4 to 10 (median ffi 7), military recruits aged 17 to 28 (median ffi 18), and in adults 30 
or more years of age (median ffi 47). The children and persons over 30 years were inmates 
of State mental institutions. Military recruits were airmen stationed at Sampson Air Force 
Base, Geneva, New York, for basic training.  1 
Immunization  and  Bleeding Schedules.--In  groups of  20  to  25,  children,  recruits,  and 
persons over 30 were bled and vaccinated according to the following plan. Four groups in 
each age category received three doses of monovalent vaccines containing either swine, PR8, 
FM1, or Cuppett  virus. Six groups received 4 different monovalent vaccines alternated  so 
that the order in which swine, PR8, or Cuppett  strains of virus was given, was varied to 
include all possible permutations, and each group received FM1 as the last vaccine. Vaccina- 
tion was carried out at 2-week intervals. Bleedings were obtained before each vaccination 
and at 2 and 4 weeks after the last. The dose of all vaccines was 1 cc. subcutaneously. 
Treatment of Sera.--Serum  was promptly  separated  from each blood sample, and mer- 
thiolate was added to  yield a  final concentration of  1:10,000. Pools of sera derived from 
samples obtained before and after  each vaccination were made by combining appropriate 
aliquots. Sera were stored at 4°C. and heated at 56°C. for 30 minutes prior to use. 
Hemagglutination-Inhibition  Titrations.--The  hemagglutination-inhibition titer  of serum 
pools was determined by a pattern method with 4 units of virus and 0.5 per cent chicken 
erythrocytes  suspended in saline. (7). 
Solutions.--Saline  refers to 0.15 ~t NaCI buffered at pH 7.2 with 0.01 ~  phosphate. 
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EXPERI~EINFfAL 
Antibody Response in Children to Mono~alent Vaccines.--Antibody  responses 
to swine,  PR8,  FM1,  and  Cuppett strains were measured in pools of serum 
obtained before and 2 weeks after vaccination with monovalent vaccines con- 
taining these viruses. In Fig. 1, pre- and post-vaccination antibody titers are 
shown  as  paired  bar graphs.  Open bars represent  antibody  levels measured 
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FIG. 1. Antibody response in children aged 4 to 10 years to monovalent influenza virus 
vaccines. 
with the strain used for vaccination. Hatched bars represent antibody levels 
measured with heterologous strains. Antibody to swine virus was not detected 
in the lowest dilution  of prevaccination sera tested. As would be expected, a 
high level of homologous antibody was found 2 weeks after vaccination with the 
swine strain. Of greater import is the antibody response after swine vaccine to 
heterologous viruses. Note that before vaccination, antibody to PR8 was in- 
apparent  and  the  level  developed  after  vaccination  was  low.  In  contrast, 
postvaccination antibody levels to FM1 and Cuppett were high, and the levels 
reached represent a  marked increase over the amounts found before vaccina- 
tion.  Analogous  results  were  obtained  by  vaccination  with  PR8.  The  ho- 88  ANTIBODY RESPONSE TO  MONOVALENT VACCINE 
TABLE I 
H-I Antibody  Tilers in Pools of Sera Obtained before and  after Administralion  of Monovalent 
Vaccines to Ckildren Aged 4 to 10" 
Vaccines given 
Swine 
Swine 
Swine 
PR8 
PR8 
PR8 
FMI 
FM1 
FMI 
Cuppett 
Cuppett 
Euppett 
~wine 
DR8 
Euppett 
FM1 
~wine 
3uppett 
PR8 
FM1 
Group  Bleeding 
1  i 
2 
3~ 
4 
5 
2  I 
2 
3 
4 
5 
3  1 
2 
3 
4 
5 
4  1 
2 
3 
4 
5 
5  1 
2 
3 
4 
5 
6 
6  1 
2 
3 
4 
5 
6 
Titer with test strains 
Swine  PR8  FM! 
0  0  256 
1,024  128  >16,384 
1,024  64  >16,384 
2,048  32  >16,384 
512  32  8,192 
0  0  1,024 
64  2,048  2,048 
64  2,048  2,048 
64  1,024  2,048 
32  1,024  2,048 
0  0  256 
0  0  4,096 
0  32  4,096 
0  32  4,096 
0  32  2,048 
0  0  256 
32  128  4,096 
0  64  8,192 
0  32  4,096 
0  32  4,096 
0  0  256 
1,024  32  >16,384 
512  512  8,192 
256  256  4,096 
256  128  8,192 
256  128  8,192 
0  0  256 
1,024  64  ~>16,384 
1,024  64  ~>16,384 
512  1,024  4,096 
512  512  4,096 
512  1,024  4,096 
Cuppett 
32 
1,024 
1,024 
2,048 
512 
64 
128 
128 
128 
128 
32 
512 
512 
256 
256 
32 
1,024 
512 
512 
512 
32 
2,048 
1,024 
512 
512 
1,024 
32 
1,024 
1,024 
512 
512 
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TABLE I---Concluded 
Vaccines  given 
PR8 
Swine 
Cuppett 
FM1 
PR8 
Cuppett 
Swine 
FM1 
Cuppett 
PR8 
Swine 
FM1 
Cuppett 
Swine 
PR8 
FM1 
Control 
No Vaccine 
Group  Bleeding 
7  1 
2 
3 
4 
5 
6 
8  1 
2 
3 
4 
5 
6 
9  1 
2 
3 
4 
5 
6 
10  1 
2 
3 
4 
5 
6 
11  1 
2 
3 
Titer with test strains 
Swine  PR8 
0  0 
128  2,048 
256  1,024 
128  1,024 
64 
64 
0 
64 
64 
256 
256 
256 
0 
64 
64 
256 
128 
128 
1,024 
512 
0 
1,024 
1,024 
512 
512 
512 
0 
256 
1,024 
512 
256 
256 
0  0 
64  128 
512  256 
256  512 
128  128 
128  128 
0  32 
0  32 
0  32 
I 
FM1  Cuppett 
256  64 
4,096  1,024 
4,096  1,024 
4,096  512 
4,096  512 
2,048  256 
128  32 
2,048  256 
4,096  512 
4,096  512 
4,096  512 
4,096  256 
256  32 
8,192  1,024 
8,192  512 
4,096  512 
4,096  512 
4,096  512 
128  0 
4,096  512 
4,096  512 
4,096  256 
2,048  256 
2,048  128 
512  32 
512  32 
512  32 
* The first bleeding was obtained at 
were carried out at 2-week intervals. 
1: Last vaccine given. 
the time of the first vaccination. Successive bleedings 
mologous antibody response was excellent. Low levels of antibody to swine virus 
developed. PR8 vaccine effected a  marked reinforcement of antibody to FM1 
and Cuppett, although the final yield of A-prime antibody was less than that 
observed after swine vaccine. Vaccination with either FM1 or Cuppett yielded 
a  good homologous antibody increase. The heterologous antibody response to 90  ANTIBODY  RESPONSE  TO  MONOVALENT  VACCINE 
the corresponding  A-prime  strain was  also  of a  high order.  However,  FM1 
vaccine did not stimulate the production of measurable antibody to swine or 
PR8 virus, and the response  after Cuppett vaccine  was minimal. 
The most striking characteristic of these  results  is  that  all  the  vaccines 
induced a  marked heterologous  antibody response  to A-prime  strains, while 
none produced more than minimal heterologous  antibody levels  to PR8  or 
swine.  These  findings  are  a  clear  demonstration of  persistent  orientation 
to antibody formation resulting from initial experience with influenza.  The 
primary infections  of this age group were influenza A-prime,  and a  marked 
heterologous  antibody response  to A-prime  strains resulted even though the 
vaccines given were as remotely related antigenically to influenza A-prime as 
PR8 and swine. 
Table I  shows antibody levels determined before  and at 2-week intervals 
after multiple vaccinations with swine, PR8, FM1, or Cuppett given alone or 
in  the  sequences  indicated.  Maximal  antibody  levels  to  homologous  and 
heterologous viruses were generally reached at 2 weeks (Groups I to IV). It is 
noteworthy that repeated vaccination of children with the same strain did not 
lead to a broadening  of heterologous antibody response to PR8 or swine. The 
dependence  of the development of significant  levels of antibody to PR8  or 
swine in children  upon vaccination with these  viruses  is emphasized  by the 
findings in Groups 5 through 10. In all instances  the appearance of high levels 
of antibody to swine or PR8 was delayed until 2 weeks after the use of the 
homologous vaccine. 
Close scrutiny of the data in Table I yields several provocative observations. 
In children, swine vaccine induced higher levels of antibody to FM1 and Cup- 
pert than did vaccination with either of these A-prime strains. (Group I, c.f. 
Groups 3 and 4). Vaccination  with PR8 was less effective in stimulating high 
levels of anti-influenza  A-prime antibodies than swine, FM1, or Cuppett vac- 
cines. (Group 2, c.f. Groups 1, 3, and 4). These findings suggest that swine virus 
contains a more representative selection of the antigenic components common 
to strains of influenza A-prime than are apparent in either PR8, FM1, or Cup- 
pett viruses. However, prior vaccination with PR8 or Cuppett viruses appeared 
in most instances to suppress the capacity of swine vaccine to stimulate maximal 
A-prime antibody levels (Groups 7 to 10, c.f. Groups 5 and 6). Further examples 
of suppression of maximal antibody yield when different vaccines were given in 
sequence are the lower titers of swine antibody found when PR8 or Cuppett 
strains were administered before swine vaccine  (Groups  7 to 10, c.f. Groups 5 
and 6),  and the lower  titer of PR8  antibody resulting when swine vaccine 
(Group  5)  or Cuppett and swine vaccines  (Group  10)  were used before PR8 
vaccine  (c.f. Groups  2,  7  to 9).  The mechanism of these results cannot be 
explained at present. Suppression  of maximal antibody yield when vaccines 
are given in sequence could result through neutralization of antigen by anti- FRED M. DAVENPORT  AND  ALBERT  V. HENNESSY  91 
bodies  already evoked by the preceding  vaccines,  or perhaps antigens given 
after the initial one may fail to provide a maximal challenge to an antibody- 
forming mechanism already stimulated to produce antibodies to closely related 
viruses. Whatever the mechanism may be, the results illustrate the suppressive 
effect of prior experience with antigenic variants of influenza viruses upon the 
antibody response to strains subsequently experienced. In this sense, the find- 
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FIG. 2. Antibody response in recruits aged 17 to 26 years to monovalent influenza virus 
vaccines. 
ings herein described after vaccination are similar to those reported previously 
after infection (2, 4). 
Antibody Response in Military Recruits to Monovalent Vaccines.--The same 
vaccines  were given to military recruits whose initial infections at childhood 
occurred during the period of prevalence of influenza A. Fig. 2 shows antibody 
levels found in pools of sera obtained before and 2 weeks after each vaccina- 
tion. In contrast to the results in children,  swine virus vaccine  produced in 
recruits a marked reinforcement of antibody to PR8, and only slightly rein- 
forced  A-prime  antibody levels.  The final titer of homologous  antibody  to 
PR8 vaccine was greater than in children but the heterologous  antibody in- 92  ANTIBODY  RESPONSE  TO  MONOVALENT  VACCINE 
crease  measured with A-prime  strains was considerably less. Vaccination  of 
recruits with A-prime strains  stimulated levels  of A-prime  antibody, which 
were lower than those observed in children. The A-prime vaccines supported 
antibody levels  to  PR8,  though to a  lesser  extent than did swine vaccine. 
Minimal heterologous antibody levels to swine virus followed the administra- 
tion of PR8 and A-prime viruses. The dominant effects of the initial influenza 
A infections  of this segment of the population upon their antibody response 
when subsequently exposed  to influenza  viruses  are again demonstrated by 
reinforcement of PR8 antibody levels by all vaccines even though they were as 
distantly related antigenically to PR8 as swine and A-prime strains. It will be 
recalled  that persons  currently of military recruit age have repeatedly been 
exposed to influenza A-prime since 1946. The spectrum of antibodies at this 
age in interepidemic  periods is broader than in childhood and comprises anti- 
body to many A and A-prime  strains (1, 2, 4). The suppressive  effect of this 
broader composite of antibody upon the serologic response to influenza viruses 
is seen by the development of lower levels of antibody to swine and A-prime 
strains in recruits,  than in children, when the homologous vaccines were given. 
The results of other experiments  in which the same vaccines  were given 
repeatedly or alternately, as described  in the preceding  section  on antibody 
response  in children,  were  confirmatory of the observations  illustrated and 
will not be presented in detail. Broadening of antibody response in recruits on 
repeated administration of the same vaccine  was not observed. 
Antibody Response  in Persons over 30 Years of Age to Monovalent  Influenza 
Virus Vaccines.--The results of previous studies led to the inference that people 
over  30  years  of  age  had  probably  encountered strains  of influenza  virus 
antigenically closely related to those of swine influenza at the time of their 
childhood  experience with influenza (1-4).  To test this inference further and 
to evaluate the antibody-orienting capacity of such childhood experiences, the 
same monovalent vaccines  were given to adults aged 30 or more.  In Fig.  3 
representative antibody levels found before and 2 weeks after vaccination are 
reproduced. In this age group antibody to swine virus is present before vaccina- 
tion (1-4).  The level of postvaccination antibody homologous for that strain 
was the highest observed  in this study. Heterologous  antibody response  to 
Swine vaccine, as measured with PR8 or A-prime strains, was the least seen in 
the  three  age  groups  tested.  PR8  vaccine  increased  heterologous  antibody 
to swine virus,  but did not consistently increase  antibody levels to A-prime 
strains. The homologous antibody response to PR8 was less than that observed 
in children or recruits.  A-prime vaccines given to persons over 30 years of age 
yielded an antibody response to the A-prime viruses used for testing similar to 
that seen in recruits,  but considerably  less than was found in children.  Rein- 
forcement of antibody levels to PR8 and to swine virus was affected by A-prime 
vaccines,  and it is  noteworthy that  the postvaccination levels  of antibody ~'RED ~.  DAVENPORT AND ALBERT V.  ttENNESSY  93 
measured with swine virus after vaccination with either PR8 or A-prime strains 
were almost equal to that observed after swine vaccine was given. 
The results observed in persons over 30 years of age add further support to 
the inference that the initial experiences of this cohort of the population were 
with viruses antigenically closely related to swine virus since reinforcement of 
antibody levels to swine virus followed the use of all of the vaccines given. 
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FIG. 3. Antibody response in persons over 30 years of age to monovalent influenza virus 
vaccines. 
Suppression of antibody response owing to the broad composite of antibodies 
characteristic of this age group, which comprises antibodies to swine, A, and 
some A-prime strains, is seen in the diminished homologous antibody response 
to PR8 vaccines. The postvaccination level reached was the lowest observed 
in this study. As in recruits, vaccination with A-prime strains led to lower levels 
of homologous antibody than use of A-prime vaccines in children. Administra- 
tion of the four monovalent vaccines repeatedly or alternately to persons over 
30 years of age did not produce a broadening of antibody response. 
Antibody  Response to Monovalent  Vaccines Measured with Many A  and A- 
prime Strains Representative of the Known Period of Prevalence of These Types of 94  ANTIBODY  RESPONSE  TO MONOVALENT  VACCINE 
Influenza Virus.--Primary experience with  influenza viruses by vaccination 
or infection leads  to  the production  ~  of antibody of limited scope,  which  in 
general  reacts  most  readily with  the  strain  responsible  for  that  particular 
antigenic stimulus. Familiar examples are those seen in the antibody response 
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FIG. 4. Antibody response to Cuppett virus vaccine  in children, recruits, and persons over 
30 years of age as measured with Type A-prime strains. 
of ferrets, mice, chickens, and occasionally of humans (8). However, it would 
seem reasonable to expect  that  the  variety of  antigenic  experiences of  the 
bulk of the human population would be much richer than that of the examples 
cited, owing to the frequent recurrence of influenza caused by the prevalence 
of viruses of different antigenic composition. In consequence, it seemed likely 
that  the  antibody response of humans  might  be broader  than  that  seen in 
experimental animals. To ascertain the dimensions of the antibody response of 
humans  to vaccines prepared from prototypic viruses, antibody levels in sera FRED  M.  DAVENPORT  AND  ALBERT  V.  HENNESSY  95 
obtained before and 2 weeks after vaccination with A and A-prime strains were 
measured with viruses isolated during the period of prevalence of these infec- 
tions. 
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FIG. 5. Antibody response to PR8 virus vaccine in children, recruits, and persons over 30 
years of age as measured with Type A strains. 
In Fig. 4, the antibody response to Cuppett vaccine in children, recruits, and 
persons over 30 years of age, as determined with A-prime strains isolated be- 
tween  1946  and  1954  is shown.  It is  evident  that  the  antibody response  to 
Cuppett vaccine as measured with antigenically and chronologically representa- 
tive strains of influenza A-prime was greatest in children, less in recruits, and 
least in persons over 30. Moreover, within each age group, the antibody response 
to the viruses used for testing were remarkably uniform. Similar results were 
obtained with  FM1  vaccine.  In Fig.  5  antibody response to PR8 vaccine as 
measured  with  representative  strains  of  influenza  A,  isolated  between  1933 95  ANTIBODY  RESPONSE  TO  MONOVALENT  VACCINE 
and  1943, is shown.  High levels of antibody were induced to all of the test 
viruses,  although  the final  yield to Melbourne (1935),  Gatenby (1937),  and 
DSP (1943) were low in children.  These findings emphasize  the richness of the 
human populations' past experience with the antigens that comprise influenza 
virus, and sharply differentiates the antibody response of humans from that 
seen in experimental animals not previously exposed to influenza viruses. 
DISCUSSION 
The  experimental  findings  reported  in  this  paper  provide  a  remarkable 
illustration of the persistent antibody-orienting effects produced by the major 
antigens of the viruses encountered  in  the  primary  infections  of childhood. 
Thus, regardless of the strain of virus given by vaccination,  the children re- 
sponded by producing antibodies to strains of influenza  A-prime,  the military 
recruits to strains of influenza  A, and the persons over 30 years of age to a 
strain of swine influenza.  The childhood infections of these three segments of 
the population were with influenza  A-prime,  with influenza  A, and with in- 
fluenza caused by swine-like strains respectively (1, 2). However, the results of 
this study disclose more than the antigenic  characteristics  of the  strains  of 
primary  infection.  They would appear  to  provide a  serologic  index  of  the 
amount of infection which each  of these three  age groups have experienced 
with influenza A-prime, influenza A, and influenza caused by swine-like strains. 
Such a serologic appraisal becomes possible because it was found that the anti- 
body response of humans to monovalent vaccines was strikingly type-specific; 
i.e.,  to swine, A, or A-prime strains, save for those instances wherein antibody 
response to heterotypic viruses could be explained by previous experience.  For 
example, in children little or no antibody to PR8 or swine virus was produced 
except by vaccination with  the homologous strain.  Nevertheless, very high 
levels of A-prime antibodies developed after vaccination with swine, Type A, 
or A-prime viruses. Clearly this result indicates that anti A-prime antibodies 
produced in human sera by vaccination show little or no intrinsic  serologic 
cross-reactivity with A or swine strains. In like vein, recruits did not develop 
more than minimal antibody levels to swine virus, despite the development of 
high  levels  of Type A  antibody. Again the lack of intrinsic  serologic  cross- 
reactivity between anti-influenza  A antibodies and swine virus is emphasized. 
If it  is granted  that  the  evidence presented  warrants  the inference  that 
heterotypic antibody response to vaccination largely reflects prior experience 
rather  than serologic  cross-reactivity, it becomes possible to reconstruct the 
previous antigenic experiences of each of the age groups studied. The antibody 
response of the children to monovalent vaccines indicates that as a group they 
have had little exposure to the dominant antigens of Type A or swine strains. 
Recruits have also had a limited experience  with the major antigens of swine 
virus but their heterotypic antibody response to strains of influenza  A-prime FRED  M.  DAVENPORT  AND  ALBERT  V.  HENNESSY  97 
indicates that this age group has had considerable experience with influenza 
A-prime,  in addition to  their primary infections with influenza A. Likewise 
persons over 30 years of age react as if after their initial infections with swine- 
like strains, they subsequently experienced an important amount of infection 
with influenza A, but a greatly diminished amount of infection with influenza 
A-prime. It would appear, therefore, that delineation of the characteristics of 
antibody response obtained in three segments of the population after vaccina- 
tion with monovalent influenza virus vaccines, provides a serologic recapitula- 
tion of each cohort's past experiences with antigenic variants of influenza virus. 
The use of vaccines for this purpose is believed to be a  new development in 
serologic epidemiology. 
SUMMARY 
The results of the present study provide a striking demonstration of antibody 
orientation produced by  the  dominant antigens of  the  strains  of  influenza 
virus encountered at childhood. The homologous and heterologous antibody 
response  to  monovalent vaccines containing swine,  PR8,  FM1,  or  Cuppett 
viruses show  that  the  antibody-forming mechanisms of children born  after 
1943 are oriented to strains of influenza A-prime; of recruits to strains of in- 
fluenza A; and of persons over 30 years of age to a  strain of swine influenza. 
It was shown that antibody response to heterotypic viruses appears to provide a 
serologic index of the amount of experience each of the segments of the general 
population studied have had with antigenic variants of influenza virus. Finally 
it was demonstrated that the antibody response of humans to strains of in- 
fluenza A or influenza A-prime is remarkably uniform for isolates of each anti- 
genic type. 
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